Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
THYREL TRH (Protirelin) is a small-molecule injectable diagnostic and therapeutic agent approved in 1978 for thyroid function assessment and thyrotropin-releasing hormone stimulation. It is used primarily as a diagnostic tool to evaluate pituitary and thyroid function in endocrinology settings. The drug works by directly stimulating the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland.
Declining commercial relevance with LOE approaching signals shrinking team and reduced promotional investment; roles focus on managed decline and cost management rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on THYREL TRH offers limited career advancement opportunity given its mature lifecycle stage and approaching loss of exclusivity. Roles are defensive in nature, focused on maintaining compliance, managing declining revenue, and optimizing operations rather than driving growth or innovation.
Worked on THYREL TRH at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.